The IPO is being offered in the price band of Rs 938-988 per share, valuing the pharmaceutical ingredients maker at around Rs 6,350 crore at the upper end of the band.
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.